Mahoney Mary C, Newell Mary S
University of Cincinnati Medical Center, Barrett Cancer Center, Cincinnati, OH 45219, USA.
Magn Reson Imaging Clin N Am. 2013 Aug;21(3):495-508. doi: 10.1016/j.mric.2013.04.001. Epub 2013 Jun 3.
Data support greater sensitivity of MR imaging compared with mammography and ultrasound in high-risk populations, in particular BRCA 1 and BRCA 2 carriers. Screening ultrasound improves cancer yield versus mammography alone in high-risk patients and in patients with dense breasts and is less expensive. Drawbacks include low positive predictive value, operator dependence, and significant physician time expenditure. Advances, such as refinement of automated whole-breast ultrasound, new outcomes data from ultrasound-detected masses in BI-RADS 3 and 4a categories, and development of new MR imaging sequences that allow rapid screening, potentially without use of contrast, will likely reveal the most appropriate tool over time.
